Novo Nordisk Is Raising the Bar on Diabetes, Obesity Drugs — Analysis

[ad_1]

Novo Nordisk is currently relaunching its diabetes drug Wegovy in the U.S., with rising capacity putting the company in a solid position to boost growth, according to analysts.

[ad_2]

Source link